Spesolimab, an interleukin-36 receptor monoclonal antibody, for the treatment of generalized pustular psoriasis
A. David Burden(King's College London)
Cited by 23
Related Papers
British Association of Dermatologists’ guidelines for biologic interventions for psoriasis 2009
|British Journal of Dermatology|2009|436